Prospective double blind study comparing two remifentanil dosing protocols (0.1 and 0.3 mcg/kg/min) during cardiac surgery. Main outcome measures are postoperative opioid requirements (PCA oxycodone) and postoperative pain (VAS, verbal rating scale).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
90
remifentanil infusion
remifentanil infusion
Kuopio University hospital
Kuopio, Finland
Postoperative opioid (oxycodone) consumption
Time frame: Postoperatively 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.